(Q35066202)

6 August 2017

1 reference

title

Mechanism of action of oritavancin and related glycopeptide antibiotics (English)

1 reference

6 August 2017

0 references

Norris E Allen

1

1 reference

PubMed ID

12586393

6 August 2017

Thalia I Nicas

series ordinal

2

1 reference

6 August 2017

1 January 2003

1 reference

FEMS Microbiology Reviews

6 August 2017

1 reference

6 August 2017

26

1 reference

6 August 2017

5

1 reference

6 August 2017

511-532

1 reference

Resistance of enterococci to glycopeptides

6 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Structure, biochemistry and mechanism of action of glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Genetics and mechanisms of glycopeptide resistance in enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

A nonribosomal system of peptide biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

The chemical basis for the action of the vancomycin group of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Molecular basis of the activity of antibiotics of the vancomycin group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

The structure and mode of action of glycopeptide antibiotics of the vancomycin group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Reversal by a specific peptide (diacetyl-αγ-l-diaminobutyryl-d-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Comparative in vitro study of teichomycin A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

The Vancomycin Group of Antibiotics and the Fight against Resistant Bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Identification of vancomycin resistance protein VanA as a D-alanine:D-alanine ligase of altered substrate specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Overexpression, purification, and characterization of VanX, a D-, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Inducible carboxypeptidase activity in vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Control of peptidoglycan synthesis in vancomycin-resistant enterococci: D,D-peptidases and D,D-carboxypeptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Utilization of a depsipeptide substrate for trapping acyl—enzyme intermediates of penicillin-sensitive D-alanine carboxypeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Bacterial resistance to vancomycin: overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care unit patient surveillance cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Vancomycin binding to low-affinity ligands: delineating a minimum set of interactions necessary for high-affinity binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Vancomycin and related antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-l-lysyl-d-alanyl-d-alanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Conformation of A82846B, a glycopeptide antibiotic, complexed with its cell wall fragment: an asymmetric homodimer determined using NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

The Roles of Dimerization and Membrane Anchoring in Activity of Glycopeptide Antibiotics against Vancomycin-Resistant Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

On the attribution and additivity of binding energies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Hexapeptide derivatives of glycopeptide antibiotics: tools for mechanism of action studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

The glycopeptide story--how to kill the deadly 'superbugs'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Differential antimicrobial susceptibility between human and chicken isolates of vancomycin-resistant and sensitive Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Study on the in-vitro activity of LY333328 against gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

Glycopeptide Antibiotic Activity and the Possible Role of Dimerization: A Model for Biological Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-6976.2003.TB00628.X

10.1111/J.1574-6976.2003.TB00628.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12586393